WASHINGTON (AP) — Makers of medical tests that have long escaped government oversight will have about four years to show that their new offerings deliver accurate results, under a government rule vigorously opposed by the testing industry. The regulation finalized Monday by the Food and Drug Administration will gradually phase in oversight of new tests developed by laboratories, a multibillion-dollar industry that regulators say poses growing risks to Americans. The goal is to ensure that new tests for cancer, heart disease, COVID-19, genetic conditions and many other illnesses are safe, accurate and reliable. “The final rule announced today aims to provide crucial oversight of these tests to help ensure that important health care decisions are made based on test results that patients and health care providers can trust,” said FDA commissioner Robert Califf, in a release. |
Takeaways from this week's reports on the deadly 2023 Maui fire that destroyed LahainaEmma Roberts fans GUSH over her 'iconic' and 'magical' $3.6 MILLION 'grownHilarious moment cheeky THREEGeorge Soros drops $60 MILLION into Democrats' war chestUkraine welcomes fresh military aid from EUCanada, Germany sign MOU to implement transatlantic hydrogen corridorAlabama Barker, 18, shares racy bikiniSchumer says US will provide $6.1 billion to Micron Technology for chip plants in NY, IdahoA Simple Favor 2 star Henry Golding dishes on hotlyNew BYU basketball coach Kevin Young focused on building NBA pipeline with Cougars